Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Prograf

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Prograf was produced by Astellas.

Interview: Ken Jones, Astellas Pharma Europe

Interview: Ken Jones, Astellas Pharma Europe Our focus is to upgrade patients from Prograf to this new standard of care.

Astellas multiple myeloma partnership

its product line-up in order to replace declining revenues from two of its own main products, the organ-rejection drug Prograf (tacrolimus) and the urology drug Flomax (tamsulosin).

Astellas sees profits fall

Prograf (tacrolimus), used to prevent the body's rejection of a transplanted organ, was particularly hard hit in the US due to generic competition, with sales decreasing 42.8 per cent

Astellas purchases OSI

The purchase of OSI will bolster Astellas' existing interests in urology and transplantation as its urinary drug, Flomax (tamsulosin), and transplant drug, Prograf (tacrolimus), recently lost patent protection in the US

Astellas announces its new five year plan

products, Prograf (tacrolimus) and Harnal (tamsulosin), and accelerate growth to a new stage. ... Despite going off patent and facing generic competition, Prograf is currently performing above expectations.

[ Previous 5 results ] 1 2 3 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

The era of digital wellbeing
Social media - friend or foe?...
World Mental Health Day 2019: Employment and Mental Illness
Mednet Group's white paper with a focus on navigating the world of work is available online in aid of World Mental Health Day 2019....
Changing direction
Changing direction: adapting to a rapidly-evolving environment
Chris Ross examines why creative partnerships could be key to commercial success in today’s healthcare marketplace...

Infographics